Dr Seal trained as a clinical neuropsychologist and has over 15 years experience in coordinating neuroimaging investigations of brain development. After completing his PhD he was awarded a Wellcome Trust International Fellowship (2001-2002) to support a two-year postdoctoral position in the Section of Neuroimaging, Institute of Psychiatry(IOP), Kings College London. Subsequently, Dr Seal was able to obtain a NARSAD Young Investigator Award (2003-2005) to continue his postdoctoral training in neuroimaging. In 2005 Dr Seal returned to Australia as a member of the Senior Research Group at The Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne. In this position he coordinated several large investigations measuring changes in brain structure and function across the life-span. On the basis of this work he was awarded the Ronald Phillip Griffith Fellowship (2007-2009). From 2007-2010 he successfully coordinated onsite Australia’s largest study investigating the neurocognitive impact of heavy cannabis use on brain development (NHMRC Project 459111).
In 2010 he was was appointed Group Leader of the Developmental Imaging research group at the Murdoch Children's Research Institute. In this role he is responsible for coordinating and facilitating research utilising the Research MRI Scanner and supervises a multidisciplinary team of clinicians, MRI technologists and neuroscientists. He is currently involved in several ongoing studies of neurodevelopment including as Chief Investigator on NHMRC Project Grants and ARC Discovery Grants. He holds a joint appointment (0.5) as a Principal Research Fellow in the Department of Paediatrics, The University of Melbourne
Dr Seal trained as a clinical neuropsychologist and has over 15 years experience in coordinating neuroimaging investigations of brain development. After completing his PhD he was awarded a Wellcome Trust International Fellowship (2001-2002) to support...
Dr Seal trained as a clinical neuropsychologist and has over 15 years experience in coordinating neuroimaging investigations of brain development. After completing his PhD he was awarded a Wellcome Trust International Fellowship (2001-2002) to support a two-year postdoctoral position in the Section of Neuroimaging, Institute of Psychiatry(IOP), Kings College London. Subsequently, Dr Seal was able to obtain a NARSAD Young Investigator Award (2003-2005) to continue his postdoctoral training in neuroimaging. In 2005 Dr Seal returned to Australia as a member of the Senior Research Group at The Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne. In this position he coordinated several large investigations measuring changes in brain structure and function across the life-span. On the basis of this work he was awarded the Ronald Phillip Griffith Fellowship (2007-2009). From 2007-2010 he successfully coordinated onsite Australia’s largest study investigating the neurocognitive impact of heavy cannabis use on brain development (NHMRC Project 459111).
In 2010 he was was appointed Group Leader of the Developmental Imaging research group at the Murdoch Children's Research Institute. In this role he is responsible for coordinating and facilitating research utilising the Research MRI Scanner and supervises a multidisciplinary team of clinicians, MRI technologists and neuroscientists. He is currently involved in several ongoing studies of neurodevelopment including as Chief Investigator on NHMRC Project Grants and ARC Discovery Grants. He holds a joint appointment (0.5) as a Principal Research Fellow in the Department of Paediatrics, The University of Melbourne
Top Publications
Allen, P, Chaddock, CA, Howes, OD, Egerton, A, Seal, ML, Fusar-Poli, P, Valli, I, Day, F, McGuire, PK.
Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis..
Schizophr Bull
38(5)
:
1040 -1049
2012
view publication
Harding, IH, Solowij, N, Harrison, BJ, Takagi, M, Lorenzetti, V, Lubman, DI, Seal, ML, Pantelis, C, Yücel, M.
Functional connectivity in brain networks underlying cognitive control in chronic cannabis users..
Neuropsychopharmacology
37(8)
:
1923 -1933
2012
view publication
Zalesky, A, Solowij, N, Yücel, M, Lubman, DI, Takagi, M, Harding, IH, Lorenzetti, V, Wang, R, Searle, K, Pantelis, C, et al.
Effect of long-term cannabis use on axonal fibre connectivity..
Brain
135(Pt 7)
:
2245 -2255
2012
view publication
Valli, I, Stone, J, Mechelli, A, Bhattacharyya, S, Raffin, M, Allen, P, Lythgoe, D, O’Gorman, R, Seal, M, McGuire, P.
Altered medial temporal activation related to local glutamate levels in subjects prodromal signs of psychosis.
Neuropsychiatrie de l Enfance et de l Adolescence
60(5)
:
s41 -s42
2012
view publication
Bhattacharyya, S, Crippa, IA, Martin-Santos, R, Allen, P, Borgwardt, S, Fusar-Poli, P, Seal, M, Zuardi, AW, Atakan, Z, McGuire, P.
THE EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL AND CANNABIDIOL ON BRAIN FUNCTION IN MAN.
Schizophrenia Research
136:
s26
2012
view publication